|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:administeredBy
|
animals
humans
|
|
gptkbp:affiliatedWith
|
aminopenicillins
|
|
gptkbp:approvedBy
|
gptkb:United_Kingdom
|
|
gptkbp:ATCCode
|
J01CA04
|
|
gptkbp:availableOn
|
gptkb:tablet
capsule
oral suspension
powder for injection
|
|
gptkbp:brand
|
gptkb:Amoxil
gptkb:Moxatag
gptkb:Trimox
|
|
gptkbp:CASNumber
|
26787-78-0
|
|
gptkbp:chemicalFormula
|
C16H19N3O5S
|
|
gptkbp:combines
|
gptkb:clavulanic_acid
|
|
gptkbp:contraindication
|
penicillin allergy
|
|
gptkbp:discoveredBy
|
gptkb:Beecham_Group
|
|
gptkbp:discoveredIn
|
1972
|
|
gptkbp:eliminationHalfLife
|
1-1.5 hours
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
amoxicillin
|
|
gptkbp:interactsWith
|
allopurinol
anticoagulants
oral contraceptives
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits bacterial cell wall synthesis
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
365.4 g/mol
|
|
gptkbp:origin
|
semi-synthetic
|
|
gptkbp:overdoseSymptoms
|
seizures
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:riskFactor
|
antibiotic resistance
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
nausea
diarrhea
allergic reaction
rash
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
gptkb:sinusitis
gptkb:pneumonia
skin infections
urinary tract infections
bacterial infections
otitis media
throat infections
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Scarlet_Fever
gptkb:Lyme_Disease
gptkb:Essential_Medicines
gptkb:antibiotic
gptkb:Penicillin
|
|
gptkbp:bfsLayer
|
5
|